Stay updated on BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Sign up to get notified when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.
Latest updates to the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page
- CheckyesterdayChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference1%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSeveral key resources related to kidney cancer, including links to MedlinePlus and NIH pages, have been removed, which may impact access to important information on renal cell carcinoma and related treatments.SummaryDifference3%
- Check23 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to kidney cancer, including links to MedlinePlus, Rare Diseases, and DailyMed, while removing the previous version 2.12.1.SummaryDifference3%
- Check37 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.0%
- Check44 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.0%
Stay in the know with updates to BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer
Enter your email address, and we'll notify you when there's something new on the BIONIKK Trial: Nivolumab vs VEGFR tKi in Kidney Cancer page.